ロード中...
Rituximab for Rheumatoid Arthritis
Rituximab is a chimeric monoclonal antibody directed at the CD20 molecule on the surfaces of some but not all B cells. It depletes almost all peripheral B cells, but other niches of B cells are variably depleted, including synovium. Its mechanism of action in rheumatoid arthritis (RA) is only partia...
保存先:
| 出版年: | Rheumatol Ther |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer Healthcare
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4883263/ https://ncbi.nlm.nih.gov/pubmed/27747531 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40744-015-0016-9 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|